Axcella Health Inc

+0.04 (+1.63%)
Earnings Announcements

Axcella Therapeutics Reports Qtrly Loss Per Share $0.41

Published: 11/10/2021 13:38 GMT
Axcella Health Inc (AXLA) - Axcella Therapeutics Reports Third Quarter Financial Results and Provides Update on Long Covid, Ohe and Nash Clinical Trials.
Axcella Health Inc - Qtrly Loss per Share $0.41.
Axcella Health - Continues to Expect Existing Cash Balance to Be Sufficient to Meet Co's Operating Needs Into Q3 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.45

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.45

More details on our Analysts Page.